TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Nature Immunology

• Publication date

  2001-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/89782PMID 11429548
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The TNF and TNF Receptor Review Superfamilies: Integrating Mammalian Biology

  2001cited by this paper
• Taci Is a Traf-Interacting Receptor for Tall-1, a Tumor Necrosis Factor Family Member Involved in B Cell Regulation

  2000cited by this paper
• Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI.

  2000cited by this paper
• April and Baff Connect Autoimmunity and Cancer

  2000cited by this paper
• TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease

  2000cited by this paper
• Lymphocyte Survival--Ignorance Is BLys

  2000cited by this paper
• Baff Binds to the Tumor Necrosis Factor Receptor–Like Molecule B Cell Maturation Antigen and Is Important for Maintaining the Peripheral B Cell Population

  2000cited by this paper
• Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity

  2000cited by this paper
• Immunology. Lymphocyte survival--ignorance is BLys.

  2000cited by this paper
• The Binding Site of Human Adenosine Deaminase for Cd26/Dipeptidyl Peptidase IV

  2000cited by this paper
• Attenuation of Apoptosis Underlies B Lymphocyte Stimulator Enhancement of Humoral Immune Response

  2000cited by this paper
• TNF Receptor Family Member BCMA (B Cell Maturation) Associates with TNF Receptor-Associated Factor (TRAF) 1, TRAF2, and TRAF3 and Activates NF-κB, Elk-1, c-Jun N-Terminal Kinase, and p38 Mitogen-Activated Protein Kinase1

  2000cited by this paper
• Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice.

  2000cited by this paper
• Identification and Characterization of a Novel Cytokine, THANK, aTNF Homologue That ActivatesApoptosis, Nuclear Factor-κB, and c-Jun NH2-Terminal Kinase*

  1999cited by this paper
• BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator.

  1999cited by this paper
• Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune Manifestations

  1999cited by this paper
• TALL‐1 is a novel member of the TNF family that is down‐regulated by mitogens

  1999cited by this paper
• APRIL, a New Ligand of the Tumor Necrosis Factor Family, Stimulates Tumor Cell Growth

  1998cited by this paper
• Death receptors: signaling and modulation.

  1998cited by this paper
• NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily.

  1997cited by this paper
• Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra.

  1996cited by this paper
• Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra.

  1996cited by this paper
• Functional differentiation of dendritic cells in rheumatoid arthritis: role of CD86 in the synovium.

  1996cited by this paper
• Monoclonal anti‐TNFα Antibody as a Probe of Pathogenesis and Therapy of Rheumatoid Disease

  1995cited by this paper
• Rheumatoid synovium is enriched in mature antigen-presenting dendritic cells.

  1994cited by this paper
• The BCMA gene, preferentially expressed during B lymphoid maturation, is bidirectionally transcribed.

  1994cited by this paper
• Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40.

  1993cited by this paper
• Type II collagen-induced murine arthritis: induction of arthritis depends on antigen-presenting cell function as well as susceptibility of host to an anticollagen immune response.

  1992cited by this paper
• Monocyte activation in rheumatoid arthritis: evidence for in situ activation and differentiation in joints.

  1990cited by this paper
• Expression of Activation Antigens on T Cells in Rheumatoid Arthritis Patients

  1990cited by this paper
• Abnormalities in CD4+ T-lymphocyte subsets in inflammatory rheumatic diseases.

  1988cited by this paper
• The preferential accumulation of helper‐inducer T lymphocytes in inflammatory lesions: evidence for regulation by selective endothelial and homotypic adhesion

  1988cited by this paper
• Experimental arthritis in a nonhuman primate. I. Induction by bovine type II collagen.

  1986cited by this paper
• Role of T lymphocytes in murine collagen induced arthritis

  1986cited by this paper
• IgG and IgM rheumatoid factor synthesis in rheumatoid synovial membrane cell cultures.

  1985cited by this paper
• Immunisation against heterologous type II collagen induces arthritis in mice

  1980cited by this paper

• ROS-dependent SOCS3 upregulation disrupts regulatory T cell stability during autoimmune disease development.

  2025cites this paper
• Synthetic receptor-based cell therapies for autoimmune diseases: an update.

  2025cites this paper
• Cytokine pathways driving diverse tissue pathologies in rheumatoid arthritis.

  2025cites this paper
• A DNA origami device spatially controls CD95 signalling to induce immune tolerance in rheumatoid arthritis

  2024cites this paper
• The emerging role of BLyS/APRIL in autoimmune diseases: Biological characteristics, functions, and therapeutic potential.

  2024cites this paper
• A proliferation-inducing ligand (APRIL) level among risk factors of ocular involvement in patients with Behçet’s disease

  2024cites this paper
• Limited efficacy of APRIL CAR in patients with multiple myeloma indicate challenges in the use of natural ligands for CAR T-cell therapy

  2023cites this paper
• Anti-TACI single and dual-targeting CAR T cells overcome BCMA antigen loss in multiple myeloma

  2023cites this paper
• A novel frameshift variant in TNFRSF13B in a Chinese patient with late-onset combined immunodeficiency.

  2022cites this paper
• Advancing Biologic Therapy for Refractory Autoimmune Hepatitis

  2022cites this paper
• The number 13 of the family: a proliferation inducing ligand.

  2021cites this paper
• Site-specific PEGylation of interleukin-2 enhances immunosuppression via the sustained activation of regulatory T cells

  2021cites this paper
• Nanomedicines in B Cell-Targeting Therapies.

  2021cites this paper
• The anti-arthritis effect of sulforaphane, an activator of Nrf2, is associated with inhibition of both B cell differentiation and the production of inflammatory cytokines

  2021cites this paper
• Review article: targeting the B cell activation system in autoimmune hepatitis

  2021cites this paper
• Impaired antibacterial response of liver sinusoidal Vγ9+Vδ2+ T cells in patients with chronic liver disease

  2021cites this paper
• Belimumab and Rituximab in Systemic Lupus Erythematosus: A Tale of Two B Cell-Targeting Agents

  2020cites this paper
• TACI Constrains TH17 Pathogenicity and Protects against Gut Inflammation

  2020cites this paper
• Short-term Immunopathological Changes Associated with Pulse Steroids/IVIG/Rituximab Therapy in Late Kidney Allograft Antibody Mediated Rejection.

  2020cites this paper
• Gut T cell–independent IgA responses to commensal bacteria require engagement of the TACI receptor on B cells

  2020cites this paper
• Autoantibody and Cytokine Profiles during Treatment with Belimumab in Patients with Systemic Lupus Erythematosus

  2020cites this paper
• Suppressed humoral immunity is associated with dengue nonstructural protein NS1-elicited anti-death receptor antibody fractions in mice

  2020cites this paper
• The Role of NF-κB in Physiological Bone Development and Inflammatory Bone Diseases: Is NF-κB Inhibition “Killing Two Birds with One Stone”?

  2019cites this paper
• Synovial tissues concentrate secreted APRIL GABAY , Cem

  2019cites this paper
• Therapeutic effects of a novel BAFF blocker on arthritis

  2019cites this paper
• Proinflammatory Differentiation of Macrophages Through Microparticles That Form Immune Complexes Leads to T- and B-Cell Activation in Systemic Autoimmune Diseases

  2019cites this paper
• NF-κB Signaling Regulates Physiological and Pathological Chondrogenesis

  2019cites this paper
• BAFF‐R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus

  2019cites this paper
• A proliferation inducing ligand (APRIL), une molécule, deux fonctions opposées dans l'autoimmunité

  2019cites this paper
• APRIL/BLyS Blockade Reduces Donor-specific Antibodies in Allosensitized Mice.

  2019cites this paper
• The role of APRIL - A proliferation inducing ligand - In autoimmune diseases and expectations from its targeting.

  2018cites this paper
• TACI‐dependent APRIL signaling maintains autoreactive B cells in a mouse model of systemic lupus erythematosus

  2017cites this paper
• Chapter 69 – Etiology and Pathogenesis of Rheumatoid Arthritis

  2017cites this paper
• The Roles of the TNF-Family Member B-Cell Activation Factor Belonging to the TNF-Family (BAFF) in Autoimmunity

  2017cites this paper
• Head-to-head comparison of protocol modifications for the generation of collagen-induced arthritis in a specific-pathogen free facility using DBA/1 mice.

  2016cites this paper
• B-Cell Activating Factor as a Cancer Biomarker and Its Implications in Cancer-Related Cachexia

  2015cites this paper
• Profile of atacicept and its potential in the treatment of systemic lupus erythematosus

  2015cites this paper
• Influencia del bloqueo del factor de necrosis tumoral-alfa sobre los niveles del factor reumatoide y anticuerpos anti-péptidos cíclicos citrulinados en pacientes con artritis reumatoide

  2015cites this paper
• Expression and effects of B-lymphocyte stimulator and its receptors in T cell-mediated autoimmune arthritis.

  2015cites this paper
• APRIL promotes proliferation, secretion and invasion of fibroblast-like synoviocyte from rats with adjuvant induced arthritis.

  2015cites this paper
• B Cell Activating Factor (BAFF) and a Proliferation Inducing Ligand (APRIL) Mediate CD40‐Independent Help by Memory CD4 T Cells

  2015cites this paper
• The rheumatoid joint

  2014cites this paper
• 69 – Etiology and Pathogenesis of Rheumatoid Arthritis

  2013cites this paper
• B-cell activating factor promoter polymorphisms in egyptian patients with systemic lupus erythematosus.

  2013cites this paper
• BAFF and TACI Gene Expression Are Increased in Patients with Untreated Very Early Rheumatoid Arthritis

  2013cites this paper
• Monoclonal antibody treatments for rheumatoid arthritis

  2013cites this paper
• Title Allogenic Mesenchymal Stem Cell Transplantation AmelioratesNephritis in Lupus Mice Via Inhibition of B-Cell Activation

  2013cites this paper
• T Cell Costimulation by the TNF Ligand

  2013cites this paper
• Tabalumab in rheumatoid arthritis patients with an inadequate response to methotrexate and naive to biologic therapy: a phase II, randomized, placebo-controlled trial.

  2013cites this paper
• Allogenic Mesenchymal Stem Cell Transplantation Ameliorates Nephritis in Lupus Mice via Inhibition of B-Cell Activation

  2013cites this paper
• Expression and function of APRIL and GDF-5 in the developing hippocampus

  2013cites this paper
• Efficacy and Safety of Belimumab in Patients with Rheumatoid Arthritis: A Phase II, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study

  2013cites this paper
• The discovery and development of belimumab: the anti-BLyS–lupus connection

  2012cites this paper
• Local gene therapy and the identification of therapeutic targets in Sjögren’s syndrome

  2012cites this paper
• An optimized B lymphocyte stimulator (BLyS) antagonist peptide inhibits the interaction of BLyS with BCMA

  2012cites this paper
• BAFF levels are increased in lesional skin and sera in patients with cutaneous T‐cell lymphoma

  2012cites this paper
• Local gene therapy and the identification of therapeutic targets in Sjögren’s syndrome

  2012cites this paper
• TACI-Fc gene therapy improves auto-immune sialadenitis but not salivary gland function in NOD mice

  2012cites this paper
• Molecular cloning, expression and functional analysis of TNF13b (BAFF) in Japanese sea perch, Lateolabrax japonicus.

  2012cites this paper
• BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus

  2012cites this paper
• TACI-Fc gene therapy improves autoimmune sialadenitis but not salivary gland function in non-obese diabetic mice.

  2012cites this paper
• BAFF Promotes Th17 Cells and Aggravates Experimental Autoimmune Encephalomyelitis

  2011cites this paper
• Elevated serum levels of a proliferation-inducing ligand in patients with systemic sclerosis: possible association with myositis?

  2011cites this paper
• Enhanced immunogenicity of pneumococcal surface adhesin A (PsaA) in mice via fusion to recombinant human B lymphocyte stimulator (BLyS)

  2011cites this paper
• Therapeutic effects of TACI-Ig on collagen-induced arthritis by regulating T and B lymphocytes function in DBA/1 mice.

  2011cites this paper
• Therapeutic effects of TACI‐Ig on rat with adjuvant arthritis

  2011cites this paper
• Regulation of B cell activating factor (BAFF) receptor expression by NF-κB signaling in rheumatoid arthritis B cells

  2011cites this paper
• [B lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis].

  2011cites this paper
• Recombinant proteins in rheumatology - recent advances.

  2011cites this paper
• Therapeutic effects of TACI-Ig on rats with adjuvant-induced arthritis via attenuating inflammatory responses.

  2011cites this paper
• Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy: results of a phase II, randomized, placebo-controlled, dose-finding trial.

  2011cites this paper
• Alpha-1 antitrypsin protein and gene therapies decrease autoimmunity and delay arthritis development in mouse model

  2011cites this paper
• A role of both NF-κB pathways in expression and transcription regulation of BAFF-R gene in multiple myeloma cells

  2011cites this paper
• Chapter 33 – Introduction of a Biologic Agent into the Clinic

  2010cites this paper
• Role of B Cells in Rheumatic Autoimmune Disease

  2010cites this paper
• Aus der Universitätsklinik für Kinder- und Jugendmedizin Tübingen Abteilung Kinderheilkunde I mit Poliklinik (Schwerpunkt: Allgemeine Pädiatrie, Hämatologie und Onkologie)

  2010cites this paper
• CD167 Acts as a Novel Costimulatory Receptor in T-Cell Activation

  2009cites this paper
• B lymphocyte stimulator expression in pediatric systemic lupus erythematosus and juvenile idiopathic arthritis patients.

  2009cites this paper
• B cell activating factor, its role in autoimmunity, and targeting in autoimmune diseases.

  2009cites this paper
• Systemic Immune-Based Rheumatic Diseases: Blissless States of BLySfulness

  2009cites this paper
• The expression of B-cell activating factor belonging to tumor necrosis factor superfamily (BAFF) significantly correlated with C4D in kidney allograft rejection.

  2009cites this paper
• Synovial tissues concentrate secreted APRIL

  2009cites this paper
• BAFF and BAFF-R of peripheral blood and spleen mononuclear cells in idiopathic thrombocytopenic purpura

  2009cites this paper
• Systemic Lupus Erythematosus (SLE) and cancer : Epidemiological and immunohistochemical studies on SLE patients with malignant lymphoma or myeloid leukaemia

  2009cites this paper
• Targeting of BAFF and APRIL for autoimmunity and oncology.

  2009cites this paper
• TACI Drives Plasma Cell Differentiation in LPS Activated B Cells

  2009cites this paper
• Recombinant proteins and genomics in cancer therapy

  2009cites this paper
• Therapeutic targets of the TNF superfamily

  2009cites this paper
• Transmembrane activator, calcium modulator, and cyclophilin ligand interactor drives plasma cell differentiation in LPS-activated B cells.

  2009cites this paper
• APRIL in B-cell malignancies and autoimmunity.

  2009cites this paper
• APRIL (TNFSF13) IN TH1, TH2 AND TH17 RESPONSES

  2009cites this paper
• B-cell activating factor (BAFF) plays a role in the mechanism of action of a tolerogenic peptide that ameliorates lupus.

  2009cites this paper
• Infiltrations of plasma cells in synovium are highly associated with synovial fluid levels of APRIL in inflamed peripheral joints of rheumatoid arthritis

  2009cites this paper
• Raised expression of APRIL in Chinese patients with immune thrombocytopenia and its clinical implications

  2009cites this paper
• Translation of BAFF Inhibition from Mouse to Non-human Primate and Human

  2009cites this paper
• In vivo identification of novel STAT5 target genes

  2008cites this paper
• APRIL facilitates viral‐induced erythroleukemia but is dispensable for T cell immunity and lymphomagenesis

  2008cites this paper
• Therapeutic advances in rheumatology with the use of recombinant proteins

  2008cites this paper
• Étude du rôle d'April, membre de la famille du TNF, dans les maladies auto-immunes

  2008cites this paper
• Update on Targets of Biologic Therapies for Rheumatoid Arthritis.

  2008influential citation